Format

Send to

Choose Destination
Nat Immunol. 2019 Sep 27. doi: 10.1038/s41590-019-0503-1. [Epub ahead of print]

'Stealth' corporate innovation: an emerging threat for therapeutic drug development.

Author information

1
National Center for Scientific Research 'Demokritos', Aghia Paraskevi, Athens, Greece.
2
Department of Translational Medicine, Lund University, Lund, Sweden.
3
Department of Neurological Surgery, Columbia University, New York, NY, USA.
4
Leiden University Medical Center, Leiden, Netherlands.
5
Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS, USA.
6
Department of Medicine, Division of Rheumatology, Allergy and Immunology, Stony Brook University, New York, NY, USA.
7
Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, Netherlands.
8
Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
9
Division of Rheumatology, Departments of Medicine and Immunology, University of Colorado School of Medicine, Denver, CO, USA.
10
Institute of Clinical and Experimental Trauma immunology, University of Ulm, Ulm, Germany.
11
Research Institute for Microbial Diseases Osaka University and Laboratory of Immunoglycobiology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
12
Department of Immunology, Oslo University Hospital, and University of Oslo, Oslo, Norway.
13
Research Laboratory, Nordland Hospital, Bodø, and K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway.
14
Centre of Molecular Inflammatory Research, NTNU, Trondheim, Norway.
15
Department of Surgery, NYU Langone Transplant Institute, New York, NY, USA.
16
Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, UK.
17
Division of Clinical Immunology, Uppsala University Hospital, Uppsala, Sweden.
18
Program in Solid Tumors, Center for Applied Medical Research (CIMA), University of Navarra, IDISNA, CIBERONC, Pamplona, Spain.
19
Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
20
Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
21
Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
22
Istituto Clinico Humanitas, Humanitas University, Milan, Italy.
23
Meta-Research Innovation Center at Stanford, and Departments of Medicine, of Health Research and Policy, of Biomedical Data Science, and of Statistics, Stanford University, Stanford, CA, USA.
24
Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. lambris@pennmedicine.upenn.edu.
PMID:
31562490
DOI:
10.1038/s41590-019-0503-1

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center